Understanding WT1 Alterations and Expression Profiles in Hematological Malignancies

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• The Wilms Tumor 1 (WT1) gene exhibits dual roles as an oncogene and tumor suppressor.
• WT1's precise function in leukemogenesis remains unclear, necessitating research using relevant model systems.
• Aberrant WT1 expression is observed in various hematologic malignancies.

Purpose of the Study:

• To investigate the role of WT1 in leukemia and lymphoma.
• To develop improved cellular models for studying WT1 in hematologic cancers.
• To analyze WT1 expression patterns and the impact of mutations on protein isoforms.

Main Methods:

• Analysis of WT1 mRNA and protein expression in 59 leukemia/lymphoma cell lines.
• Sequencing of WT1 gene locus and other myeloid risk factor genes.
• Development of a lentiviral vector for stable WT1 isoform overexpression.
• Investigation of nonsense-mediated mRNA decay (NMD) impact on mutated WT1 alleles.

Main Results:

• WT1 mRNA dysregulation was observed, but did not consistently correlate with protein levels.
• WT1 mutation status did not affect the expression patterns of the four major WT1 protein isoforms.
• Novel genetic alterations in the WT1 locus and other myeloid risk genes were identified.
• Inhibition of NMD revealed robust degradation of mutated WT1 alleles under physiological conditions.

Conclusions:

• WT1's complex role in leukemia requires further investigation using advanced model systems.
• The developed lentiviral tool facilitates stable overexpression of WT1 isoforms, aiding research.
• Understanding WT1 allele degradation pathways provides crucial insights into its function in hematologic malignancies.